Off-market insider buying at NervGen Pharma (NGEN)
Adam Rogers, a Director and 10% Holder, acquired $5,335,201 worth of the company's shares for various holders at a price of US$2.100 through a private transaction on November 19th, 2025. This represents an account share holdings change of 62.8%.
Let the insiders guide you to opportunity at Canadianinsider.com.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.